Product Information

IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML is a generic product labeled by Nephron Pharmaceuticals Corporation, priced at $0.0856 per ML under NDC 00487020160. Its NADAC has been published 657 times since Nov 28, 2013.

The Low Outlier badge above means this manufacturer's average price in the Ipratropium Bromide and Albuterol Sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML

Ipratropium Bromide and Albuterol Sulfate
$0.0856per ML
Low Outlier

Strength

3; .5 mg/3mL; mg/3mL

NDC

00487020160

Classification

Generic

Dosage Form

SOLUTION

Route

RESPIRATORY (INHALATION)

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076749

On Market Since

12/31/2007

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
beta2-Adrenergic Agonist

Price Statistics

The NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 12.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0856 per ML
All-time high$0.0892 (Mar 12, 2025)
All-time low$0.0506 (Jan 23, 2019)
52-week high$0.0863
52-week low$0.0804
Median price$0.0621
Average price$0.0660
Largest weekly change+14.3% (Mar 20, 2024)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+2.1%

3M

+1.4%

6M

+0.4%

1Y

+6.5%

3Y

+18.3%

5Y

+49.1%

All

+12.5%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?

The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML, manufactured by Nephron Pharmaceuticals Corporation, is $0.0856 per ML (NDC 00487020160), effective Jun 24, 2026.

How has the price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML changed over time?

Over the history we have for it, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has risen 12.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?

Since Nov 28, 2013, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has ranged from a low of $0.0506 (Jan 23, 2019) to a high of $0.0892 (Mar 12, 2025), with a median of $0.0621 per ML.

Are there cheaper alternatives to IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?

Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML, is $0.0723 per ML — about 16% below IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML.

Who manufactures IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?

IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML (NDC 00487020160) is labeled by Nephron Pharmaceuticals Corporation, and CMS classifies it as a generic product.